Related Experiment Video
Updated: May 10, 2026

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
Autoinflammatory encephalopathy due to PTPN1 haploinsufficiency: a case series
Gaofeng Zhu1, Blaise Didry-Barca2, Luis Seabra2
1MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
Mutations in PTPN1 cause a rare autoinflammatory encephalopathy driven by type I interferon (IFN) signaling. This condition affects children, leading to neurological decline, but some show improvement with or without treatment.
Area of Science:
- Genetics and Molecular Biology
- Immunology
- Neurology
Background:
- Identified patients with uncharacterized phenotypes showing upregulated type I interferon (IFN) signaling.
- Discovered heterozygous mutations in PTPN1, encoding protein-tyrosine phosphatase 1B (PTP1B).
- Aimed to characterize the clinical, molecular, and cellular aspects of this novel disease.
Purpose of the Study:
- To describe the clinical phenotype of a newly identified disease caused by PTPN1 mutations.
- To investigate the molecular and cellular pathology associated with PTPN1 variants.
- To understand the role of PTP1B in type I IFN signaling.
Main Methods:
- Case series involving 12 patients from 11 families across Europe and Israel.
- Genetic analysis including exome and Sanger sequencing to identify PTPN1 variants.
- Quantitative PCR, NanoString, and cell-based assays to assess gene expression and IFN signaling in patient cells.
Main Results:
- Identified ten novel or rare PTPN1 variants in heterozygous patients.
- Clinical phenotype characterized by subacute onset of motor and language skill loss, spastic dystonia, and bulbar involvement.
- Demonstrated PTPN1 variants led to reduced PTP1B levels and impaired negative regulation of type I IFN signaling, with elevated IFN-stimulated genes in patients.
Conclusions:
- PTPN1 haploinsufficiency results in a type I IFN-driven autoinflammatory encephalopathy.
- Some patients experienced neurological stabilization or recovery spontaneously, while others responded to immune suppression.
- Further prospective studies are required to evaluate specific immune suppression strategies.
More Related Videos
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
07:30A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
Published on: November 9, 2017
Related Concept Videos
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Hepatic Encephalopathy
Acute Pancreatitis II: Pathophysiology
Chronic Pancreatitis I: Introduction